Index - 28 - 29 - 30/31 - 32/33/34 - 35 - 36/37/38/39 - 40/41 - 42/43 - 44/45/46 - 47/48 - 49 - 50/51/52/53
54/55 - 56 - 57/58 - 59 - 60/61 - 62 - Pages online: A - B - C - D - E - F - G - References
LIST OF SELECTED DERMAL / SOFT TISSUE FILLERS USED FOR RESTORATIVE TREATMENT
More than 30 products are in use. Only some have been studied in HIV-positive people. The list is not exhaustive.
Advantages Disadvantages Products
Temporary fillers (bio-absorbable)

Lower risk of complication, or serious complication (e.g. foreign body reactions, granulomas, misplaced injection etc)
Multiple treatments allows for more natural cumulative correction.

Re-treatment necessary
Multiple treatments needed for severe lipoatrophy.
  • Polylactic acid i (New Fill, Sculptra).
  • Hyaluronic acid (Restylane, Perlane, Hylaform).
  • Calcium hydroxylapatite i (Radiesse).
  • Collagen (Zyderm, Zyplast, Cosmoderm)
  • Autologous fat transplant
Permanent fillers (non-absorbable) Permanent effect.
Fewer treatment sessions required.

Difficult or impossible to remove, if complications occur.
Potential migration.
  • Polyacrylamide (Aquamid)
  • Polymethylmethacrylate / PMMA (Artefill, Artecoll, Metacrill).
  • Polyalkylimide (Bio-Alcamid).
  • Expanded polytetrafluoroethylene / ePTFE (Gore-Tex, Softform).
i Approved by FDA for the treatment of facial lipoatrophy in HIV-infected patients. None of the products are approved by the EMEA to treat HIV-associated lipodystrophy.